Anti-HBc

Hepatitis B is a serious global infection disease and a major cause of mortality and morbidity. It is the 10th leading cause of death, with two billion people infected, and an estimated 400 million suffering from chronic hepatitis B virus (HBV) infection worldwide [1-5]. HBV endemicity has varied widely worldwide. It has been estimated that HBV is highly endemic in all of Africa (except Tunisia and Morocco), some parts of South America, Alaska, northern Canada and parts of Greenland, eastern Europe, the eastern Mediterranean area, south-east Asia, China, and the Pacific Islands (except Australia, New Zealand and Japan). Hepatitis B is a serious global infection disease and a major cause of mortality and morbidity. It is the 10th leading cause of death, with two billion people infected, and an estimated 400 million suffering from chronic hepatitis B virus (HBV) infection worldwide . HBV endemicity has varied widely worldwide. It has been estimated that HBV is highly endemic in all of Africa (except Tunisia and Morocco), some parts of South America, Alaska, northern Canada and parts of Greenland, eastern Europe, the eastern Mediterranean area, south-east Asia, China, and the Pacific Islands (except Australia, New Zealand and Japan) Liver markers including aspartate aminotransferase (AST) and alanine aminotransferase (ALT) were performed on HBV-PCR positive samples. The tests’ results were in 32.4% of samples higher than the upper range of normal levels for these tests in clinical diagnostic settings. 4.4% of subjects had abnormal PT or INR . Positive predictive value for livermarkers was 35.3 %. Maryam Delavari, Frequency of Anti-HBc & HBV DNA detection in blood donors of Kerman province, Iran

• Share this page
• 
• 
• 
• 
• 
• 

Last date updated on April, 2024